Press Releases
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson
IBM and Teva Pharmaceutical Industries Ltd announce a significant expansion of their existing global e-Health alliance with a focus on two key healthcare challenges: the discovery of new treatment options and improving chronic disease management. Both projects will run on...
Press Releases
Phlexglobal Provides a Global Consolidated eTMF Solution for Bayer
Phlexglobal, pioneers in the specialist provision of electronic Trial Master File (eTMF) technology and TMF services to the life sciences industry announces the success of its market leading eTMF, PhlexEview, as the eTMF solution for the Pharmaceuticals Division of...
Press Releases
An industry congregation of over 250 Indian and global companies at analytica Anacon India and India Lab Expo 2016
Analytica Anacon India and India Lab Expo, India’s leading trade fairs for laboratory technology, analysis, biotechnology and diagnostics market, kicked of its 9th edition at the Hitex exhibition center in Hyderabad 20th October 2016. The twin...
Press Releases
Particle Works offers bespoke microencapsulation for drug development
Particle Works – the nano- and microstructured material specialist – provides microencapsulation services for drug development applications, including controlled drug release, solubility enhancement or targeted drug delivery. Using its expertise in microfluidics and nanoparticle synthesis, the...
Press Releases
WuXi AppTec Unveils Manufacturing Center for Cutting Edge Cell and Gene Therapies
WuXi AppTec a leading pharmaceutical, biotechnology, and medical device technology platform company, celebrated the grand opening of their new 150,000 square foot bio manufacturing facility in an event attended by Pennsylvania Lieutenant Governor Mike Stack and WuXi AppTec Chairman...
Press Releases
Orexo receives US FDA approval for low dosages of Zubsolv to treat opioid dependence
Orexo AB announced that it has received approval from the US FDA of a new unique low dose, 0.7mg/0.18 mg, tablet of Zubsolv (buprenorphine/naloxone) sublingual tablet (CIII) for the treatment of opioid dependence. The new dosage is expected to...
Press Releases
MEDICAL MANUFACTURING ASIA 2016: Positive showing with top quality prospects
MEDICAL MANUFACTURING ASIA 2016 closed on 2 September to a positive note of 5,200 quality trade visitors from 38 countries, with more than 30% coming from overseas. The importance of MEDICAL MANUFACTURING ASIA 2016 as an...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read